SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

2014: Year of the IPO and consolidation for CROs

With PRA and INC Research joining Parexel, Quintiles, Covance and Icon in the land of public companies, 2014 was a year in which the top shelf of CROs filled out.

NYSE

UPS continues European buying spree with Poland’s Poltraf

US package delivery giant UPS has announced it will buy Polish healthcare logistics firm Poltraf SP zoo from private equity fund Ortie Capital Investment.

Baxter recalls broken saline vials

Baxter has recalled two batches of saline injections after healthcare workers noticed parts of the vial had broken into the product.

IAG Cargo receives EU GDP accreditation... and Igs might fly!

British Airways and Iberia’s cargo division IAG has become the first airline to be awarded accreditation under new EU Good Distribution Practices (GDP) guidelines.

PPD’s X-Chem licenses cardiovascular drug discovery program to Bayer

PPD’s biotech company X-Chem has licensed a second drug discovery program to Bayer Pharma, which follows on a multi-target collaboration the companies established in 2012. 

AstraZeneca will outsource Crestor API following UK plant closure

The closure of an API plant in the UK will lead to opportunities for third party manufacturers, AstraZeneca has said.

Cromos offers free clinical trials to cash-strapped small and mid-sized pharmas

Cromos Pharma has launched a free or reduced cost trial model to help small and mid-sized drugmakers overcome the funding Catch-22 that can derail development efforts.

Undeterred by Ukrainian unrest, KCR acquires portfolio of clinical projects

European CRO KCR has acquired a portfolio of clinical projects from the Ukrainian CRO Axis Group thereby making the country the most important location for KCR in the region of the Commonwealth of Independent States (CIS).

WIL IT software deal speed up US FDA drug evaluations? Yes says Instem

Regulatory reviewers spend more time managing incoming data than on the drug evaluation process, says Instem which has inked a deal with WIL Research for its nonclinical IT systems.

Spotlight

Medidata: Digital biomarkers are the future of clinical trials

Medidata: Prepare to embrace digital biomarkers in trials or lose competitiveness

The advent of Big Data in clinical trials will mean companies not using digital biomarkers are unlikely...

More details on Cetero/PRACS implosion come to light

More details on Cetero/PRACS implosion come to light

Lachman Consultants has revealed more of the story behind the decline of the now bankrupt CRO Cetero/PRACS,...

UK Hospitals to play part in Gov efforts to speed clinical trial process

UK Hospitals to play part in Gov efforts to speed clinical trial process

UK life sciences minister George Freeman wants hospitals to play more of a role in clinical trials...

Quintiles CEO: Innovation coming from CROs takes pressure off pharma
Dispatches from FT Global Pharmaceutical and Biotechnology conference, London

Quintiles CEO: Change in R&D paradigm must come from Pharma's boardrooms

Vertical integration is inhibiting pharma R&D innovation, according to Quintiles CEO Tom Pike who says executives must...

New Ricerca CEO remains positive as questions linger over company

New Ricerca CEO remains positive as questions linger over company

As questions continue to be raised over why Ricerca was on the brink of closure and laying...

'Killer experiments' and reimbursement are the keys to VC backing says Index

'Killer experiments' and reimbursement are the keys to VC backing says Index

Investors only back drug innovators because they have to according to Index Venture Management's Kevin Johnson, who...

Key Industry Events

 

Access all events listing

Our events, Events from partners...